Δ 9-Tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed

British Journal of Pharmacology

Volumn 152, Issue 5, 2007, Pages 709-716

  Wilkinson, J D ^a   Kendall, D A ^a   Ralevic, V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Calcitonin gene related peptide; Cannabinoids; Perfused mesentery; Sensory nerves

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CAPSAZEPINE; DRONABINOL; RUTHENIUM RED; SODIUM CHLORIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VANILLOID RECEPTOR 1;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY PERFUSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ELECTROSTIMULATION; EVOKED RESPONSE; IMMUNOASSAY; INHIBITION KINETICS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE; SENSORY STIMULATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; INDOLES; MALE; MESENTERIC ARTERIES; METHOXAMINE; NEURONS, AFFERENT; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RUTHENIUM RED; TETRAHYDROCANNABINOL; TIME FACTORS; VASODILATION;

EID: 35648997011     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707448     Document Type: Article

References (22)

1. Alexander SPH, Mathie A, Peters JA (2006). Guide to receptors and channels. Br J Pharmacol 147 (Suppl 3): S120-S125.
2. Bianchi BR, Lee C-H, Jarvis MF, Kouhen RE, Morelland RB, Faltynek CR et al. (2006). Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system. Eur J Pharmacol 537: 20-30.
3. Duncan M, Kendall DA, Ralevic V (2003). The effects of ruthenium red on the inhibitory actions of noladin ether, THC and HU210 on sensory neurotransmission in the rat isolated mesenteric arterial bed. 1st European Workshop on Cannabinoid Research, http://www.ucm.es/info/seic-web/abstract-book. pdf.
4. Duncan M, Kendall DA, Ralevic V (2004). Characterisation of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. J Pharmacol Exp Ther 311: 411-419.
5. Holzer P (1992). Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121: 49-146.
6. Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED et al. (2004). Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260-265.
7. Kawasaki H, Takasaki K, Saito A, Goto K (1988). Calcitonin generelated peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335: 164-167.
8. Lam PMW, McDonald J, Lambert DG (2005). Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids. Br J Anaesthesia 94: 649-656.
9. Lan R, Liu Q, Fan P, Lin S, Frenando SR, McCallion D et al. (1999). Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42: 769-776.
10. Maggi CA, Meli A (1988). The sensory-efferent function of capsaicin-sensitive neurons. Gen Pharmacol 19: 1-43.
11. 9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. Br J Pharmacol 145: 514-526.
12. 9- tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric oxide synthase. J Pharmacol Exp Ther 321: 663-672.
13. Pertwee RG (2006). The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obesity 30: S13-S18.
14. Ralevic V (2003). Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol 472: 1-21.
15. Ralevic V, Kendall DA (2001). Cannabinoid inhibition of capsaicinsensitive sensory neurotransmission in the rat mesenteric arterial bed. Eur J Pharmacol 418: 117-125.
16. Randall MD, Kendall DA, O' Sullivan S (2004). The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142: 20-26.
17. 2 cannabinoid receptors of L759633, L759656 and AM630. Br J Pharmacol 126: 665-672.
18. Rousseau E, Cloutier M, Morin C, Proteau S (2005). Capsazepine, a vanilloid antagonist, abolished tonic responses induced by 20-HETE on guinea pig airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 288: L460-L470.
19. Wagner JA, Varga K, Járai Z, Kunos G (1999). Mesenteric vasodilatation mediated by endothelial anandamide receptors. Hypertension 33: 429-434.
20. White R, Hiley R (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br J Pharmacol 125: 533-541.
21. 2 cannabinoid receptor-independent mechanism. J Neurosci 22: 4720-4727.
22. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Dimarzo V, Julius D, Högestätt ED (1999). Vacilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.